NCT04739956

Brief Summary

To assess the psychological impact of pregnancy of unknown location (PUL) classification pending a final diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 5, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

January 15, 2025

Completed
Last Updated

January 15, 2025

Status Verified

January 1, 2025

Enrollment Period

1.3 years

First QC Date

February 1, 2021

Results QC Date

March 15, 2024

Last Update Submit

January 14, 2025

Conditions

Keywords

Pregnancy of unknown locationPULEctopic pregnancyAnxiety

Outcome Measures

Primary Outcomes (1)

  • Psychological Morbidity

    Psychological morbidity will be assessed using the Hospital Anxiety and Depression Scale on time of PUL classification, 48 hours from PUL classification and following final diagnosis and management. For both Anxiety and Depression, participants can score anywhere from 0 to 21. Score of 11 and above indicate moderate to severe anxiety and depression.

    0 hours, 48 hours and point of diagnosis (within 2 wees)

Study Arms (2)

Patient: point of care (POC) result not shared

Patients in this phase of the study will not be provided with the POC BhCG result. They will await the laboratory result. Simultaneously we will ascertain reliability of POC in clinical practice during this time.

Other: The Hospital and Anxiety Depression ScaleOther: Point of care testing (POCT)

Patient: point of care (POC) result shared

Patients in this phase will be informed of the POC test result, which will reduce the time to which they receive the result. Prior to transfer to this phase, correlation between POC and laboratory BhCG levels will be calculated in order to confirm its reliability by creating a correlation curve using the data.

Other: The Hospital and Anxiety Depression ScaleOther: Point of care testing (POCT)

Interventions

Patients and partners will be asked to complete the questionnaire at three time points: 1) On classification of PUL at time zero once blood is taken, 2) at the 48-hour time point after blood is taken (if 48 hour bloods are required for the patient); and 3) after definitive diagnosis and management.

Patient: point of care (POC) result not sharedPatient: point of care (POC) result shared

Patients will have 1ml sample of blood taken for POCT at two time points: 1) On classification of PUL at time zero at the same time as when routine blood samples taken; and 2) at the 48-hour time point at the same time as when routine blood samples are taken (if 48 hour bloods are required).

Patient: point of care (POC) result not sharedPatient: point of care (POC) result shared

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women attending the Early Pregnancy Unit in the first trimester (up to 14 weeks gestation) with a pregnancy of unknown who are over 18 years old and are able to give consent.

You may qualify if:

  • Pregnant women attending the Early Pregnancy Unit in the first trimester (up to 14 weeks gestation) with a pregnancy of unknown who are over 18 years old and are able to give consent.

You may not qualify if:

  • Presence diagnosed with cancer
  • The presence of an acute medical condition
  • Patients/partners aged less than 18 years
  • Patients or partners who cannot give fully informed study consent (language or learning impairment)
  • Presence of a viable intrauterine pregnancy, ectopic pregnancy and miscarriage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College Healthcare NHS Trust

London, W12 0HS, United Kingdom

Location

Related Publications (1)

  • Kyriacou C, Yang W, Kapur S, Maheetharan S, Pikovsky M, Parker N, Barcroft J, Bobdiwala S, Sur S, Stalder C, Gould D, Ofili-Yebovi D, Day A, Unsworth N, Wilkes EH, Tan T, Bourne T. Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices. Clin Chem Lab Med. 2023 Oct 30;62(4):664-673. doi: 10.1515/cclm-2023-0703. Print 2024 Mar 25.

MeSH Terms

Conditions

Pregnancy, EctopicAnxiety Disorders

Interventions

Point-of-Care Testing

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Point-of-Care SystemsPatient Care ManagementHealth Services Administration

Results Point of Contact

Title
Dr Margaret Pikovsky
Organization
Imperial College Healthcare NHS Trust

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2021

First Posted

February 5, 2021

Study Start

December 2, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

January 15, 2025

Results First Posted

January 15, 2025

Record last verified: 2025-01

Locations